| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.005 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.09 | 0.005 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.078 | 0.006 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.006 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.084 | 0.006 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.007 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.091 | 0.007 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.099 | 0.007 |